Literature DB >> 14710348

Nutrition, insulin, insulin-like growth factors and cancer.

E Giovannucci1.   

Abstract

The incidence of colon, pancreatic, and kidney cancers, as well as aggressive prostate cancer in men, and breast and endometrial cancer in women is invariably high in Western countries. Nutritional and related factors have been typically implicated. This review presents a model integrating nutrition, insulin and IGF-1 physiology ("bioactive" IGF-1), and carcinogenesis based on the following: (1) insulin and the IGF-1 axis function in an integrated fashion to promote cell growth and survival; (2) chronic exposure to these growth properties enhances carcinogenesis; (3) factors that influence bioactive IGF-1 will affect cancer risk. The model presented here summarizes the data that chronic exposure to high levels of insulin and IGF-1 may mediate many of the risk factors for some cancers that are high in Western populations. This hypothesis may help explain some of the epidemiologic patterns observed for these cancers, both from a cross-national perspective and within populations. Of particular importance is that some of relevant factors are modifiable through nutritional and lifestyle interventions. Out of a variety of perspectives presented, nutritional manipulation through the insulin pathway may be more feasible than attempting to influence total IGF-1 concentrations, which are determined largely by growth hormone. Further study is required to test these conclusions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710348     DOI: 10.1055/s-2004-814147

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  85 in total

Review 1.  [Physical activity for primary prevention of prostate cancer. Possible mechanisms].

Authors:  H C Heitkamp; I Jelas
Journal:  Urologe A       Date:  2012-04       Impact factor: 0.639

Review 2.  Osteosarcoma and acromegaly: a case report and review of the literature.

Authors:  G A B Lima; E M S Gomes; R C Nunes; L Vieira Neto; A P A V Sieiro; E P Brabo; M R Gadelha
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

3.  Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study.

Authors:  Jennifer Prescott; Ying Bao; Akila N Viswanathan; Edward L Giovannucci; Susan E Hankinson; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-23       Impact factor: 4.254

4.  Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.

Authors:  Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

Review 5.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

Review 6.  The Impact of Diet on Breast Cancer Outcomes.

Authors:  Lai Xu; Lindsay L Peterson
Journal:  Curr Nutr Rep       Date:  2019-09

Review 7.  Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer.

Authors:  Angelos K Sikalidis; Behzad Varamini
Journal:  Pathol Oncol Res       Date:  2011-01-09       Impact factor: 3.201

8.  Objective habitual physical activity and estradiol levels in obese Latina adolescents.

Authors:  Lauren E Gyllenhammer; Amanda K Vanni; Courtney E Byrd-Williams; Marc Kalan; Leslie Bernstein; Jaimie N Davis
Journal:  J Phys Act Health       Date:  2012-10-04

9.  Size matters: height, cell number and a person's risk of cancer.

Authors:  Leonard Nunney
Journal:  Proc Biol Sci       Date:  2018-10-24       Impact factor: 5.349

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.